Trial Profile
Evaluation of Health-Related Quality of Life in Patients With Overactive Bladder Syndrome (OAB) Treated With Propiverine, and Its Efficacy and Tolerance in Daily Practice in Belgian General Practitioners and Urologists
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jan 2014
Price :
$35
*
At a glance
- Drugs Propiverine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Takeda
- 08 Jan 2014 New trial record